Yosef Yarom - Equital External Director
EQTL Stock | 10,160 20.00 0.20% |
Director
Mr. Yosef Yarom was appointed External Director at Equital Ltd effective October 2, 2017. His work experience includes the following roles Independent Director at Bank Hapoalim B.M., External Director at Bank Hapoalim B.M., Chief Internal Auditor at Bank Hapoalim B.M., Head of Risk Management at Bank Hapoalim B.M., Director at a variety of Companies, Chairman of the Board of Directors at Bank Massad Ltd. and Lecturer on Auditing at Haifa University since 2017.
Age | 75 |
Tenure | 7 years |
Phone | 972 3 9229225 |
Equital Management Efficiency
The company has return on total asset (ROA) of 0.0445 % which means that it generated a profit of $0.0445 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1814 %, meaning that it generated $0.1814 on every $100 dollars invested by stockholders. Equital's management efficiency ratios could be used to measure how well Equital manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Edith Lusky | Bezeq Israeli Telecommunication | 66 | |
Ytzhak Edelman | Bezeq Israeli Telecommunication | 64 | |
Orna Peled | Bezeq Israeli Telecommunication | 45 | |
Shmuel BenZvi | Bank Leumi Le Israel | 57 | |
Shai Hermesh | Bank Leumi Le Israel | 70 | |
Amnon LipkinShahak | El Al Israel | 68 | |
Gerald Lieberman | Teva Pharmaceutical Industries | 72 | |
Yitzhak Sharir | Bank Leumi Le Israel | 66 | |
Moshe Many | Teva Pharmaceutical Industries | 85 | |
Yoav Nardi | Bank Leumi Le Israel | 72 | |
Doron Turgeman | Bezeq Israeli Telecommunication | 49 | |
Roberto Mignone | Teva Pharmaceutical Industries | 47 | |
Orly Guy | Bezeq Israeli Telecommunication | 56 | |
Ehud Mezuman | Bezeq Israeli Telecommunication | 62 | |
Shlomo Hanael | El Al Israel | 66 | |
Efraim Sadka | Bank Leumi Le Israel | 68 | |
Dafna Cohen | El Al Israel | 53 | |
Yitzhak Peterburg | Teva Pharmaceutical Industries | 65 | |
David Avner | Bank Leumi Le Israel | 64 | |
Moshe Dovrat | Bank Leumi Le Israel | 69 | |
Dan Suesskind | Teva Pharmaceutical Industries | 72 |
Management Performance
Return On Equity | 0.18 | |||
Return On Asset | 0.0445 |
Equital Leadership Team
Elected by the shareholders, the Equital's board of directors comprises two types of representatives: Equital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Equital. The board's role is to monitor Equital's management team and ensure that shareholders' interests are well served. Equital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Equital's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zeev Chayoth, External Director | ||
Noa Lendler, General Counsel, Secretary | ||
Preal Attias, Ex Officer | ||
Eddy Francis, Chief Inc | ||
Raanan Ellran, External Director | ||
Noa Lendner, General Counsel, Secretary | ||
Micha Adania, Director | ||
Eran Lendner, Chief Officer | ||
Ronit Jacob, Director | ||
Eran Saar, CEO | ||
Ron Maor, CEO Partner | ||
Eitan Voloch, Chief Officer | ||
Gilad Richman, External Director | ||
Shaul Zeev, Director | ||
Haim Tsuff, Director | ||
Ronen Peretz, Director | ||
Yosef Yarom, External Director |
Equital Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Equital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.18 | |||
Return On Asset | 0.0445 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.60 % | |||
Current Valuation | 10.14 B | |||
Shares Outstanding | 36.89 M | |||
Shares Owned By Insiders | 37.19 % | |||
Shares Owned By Institutions | 16.46 % | |||
Price To Earning | 849.43 X | |||
Price To Book | 0.79 X |
Pair Trading with Equital
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equital will appreciate offsetting losses from the drop in the long position's value.Moving together with Equital Stock
0.76 | DLEKG | Delek Group | PairCorr |
The ability to find closely correlated positions to Equital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equital to buy it.
The correlation of Equital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equital moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equital. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Equital Stock analysis
When running Equital's price analysis, check to measure Equital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equital is operating at the current time. Most of Equital's value examination focuses on studying past and present price action to predict the probability of Equital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equital's price. Additionally, you may evaluate how the addition of Equital to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |